NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy

Written by

in

Proposed share consolidation of up to 30:1 intended to support potential U.S. exchange listing and broaden investor appeal

Originally published via Source Article.